Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR09 in healthy subjects
NCT02027155Phase 1Terminated
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Anesthesia comparing AR09 solution with Placebo (2 arms). Primary endpoint: Maximum Tolerated Dose at 4 hours. Started Dec 2013; status: terminated.
02
Drugs
AR09
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT02027155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027155.